Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Schiller
ElsMed

MR Linac Research Consortium to Develop MRI-Guided Radiotherapy for Cancer Treatment

By Medimaging International staff writers
Posted on 16 Jun 2014
High-powered institutions to join consortium to advance MRI-guided radiptherapy. Elekta (Stockholm, Sweden) and Philips Healthcare (Best, The Netherlands) reported that The Institute of Cancer Research (ICR), London, UK), a world-leading cancer research institution, working with its clinical partner the Royal Marsden NHS [National Health Service] Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with an objective to develop an integrated magnetic resonance imaging (MRI)-guided radiation therapy system. Combining a sophisticated digital linac with an MRI system would greatly enhance real-time visualization of cancer targets during the delivery of therapeutic radiation.

“The addition of The Institute of Cancer Research [ICR] to the consortium further strengthens this growing partnership of clinical centers,” said Niklas Savander, Elekta president and CEO. “The ICR is a prominent cancer research institute and has contributed significantly in this arena for over a century. Its unique partnership with The Royal Marsden and ‘bench-to-bedside’ approach allows the ICR to deliver exceptional results. All of these factors make the ICR and The Royal Marsden a perfect fit as we advance MRI-guided radiotherapy.”

“The development of MRI-guided radiation therapy establishes a new vision for clinical radiation oncology for the treatment of cancer,” said Prof. Uwe Oelfke, MCCPM, FInstP, and head of the joint department of physics at The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust. “The translation of this novel technical approach into clinical practice faces a number of challenges ideally addressed by a group of world leading radiotherapy centers, each contributing with its specific expertise. Being a member of the consortium is a prerequisite to shape this exciting future of radiation therapy. Our current Cancer Research UK-funded research program on adaptive and image-guided therapy, together with the activities on MRI within our Cancer Research UK imaging center, are an excellent research environment to make leading contributions to the joint efforts of the consortium. The ICR's initial research focus for MRI-guided radiation therapy will be on pelvic malignancies, where the excellent soft tissue contrast of MR images directly before or during treatment will substantially enhance treatment options and quality.”

The ICR is the sixth member to join the research consortium that assesses the novel technology, which brings together state-of-the-art radiation therapy and MRI in a single system. The consortium also includes the University Medical Center Utrecht (Utrecht, the Netherlands), The University of Texas MD Anderson Cancer Center (Houston, TX, USA), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, the Netherlands), Sunnybrook Health Sciences Center (Toronto, Ontario, Canada) and The Froedtert & Medical College of Wisconsin Cancer Center (Milwaukee, WI, USA).

“MRI-guided radiation therapy has the promise to become a highly targeted treatment for cancer,” said Gene Saragnese, CEO imaging systems at Philips Healthcare. “The realization of this promise requires the collaboration between leaders in interventional imaging and radiation therapy delivery, as well as clinical innovators in oncology. We are convinced that the deep clinical knowledge and expertise of the Institute of Cancer Research will be a strong asset to the growing research consortium.”

The research consortium, since its launch in 2012, has taken several steps toward its goal. On April 5, 2014, the University Medical Center Utrecht began installing the first generation MRI-guided radiation therapy system for nonclinical testing, which includes the performance evaluation of MRI pulse sequences, evaluation of different adaptive delivery approaches, establishing quality assurance techniques and defining workflow. Several of the sites are now undertaking treatment planning evaluation using the Monte Carlo based MRI-corrected algorithms in a research version of Elekta’s Monaco treatment planning system. Furthermore, a number of the consortium centers have active research programs linked to the MRI-guided radiation therapy system and have submitted abstracts to the American Association of Physicists in Medicine (AAPM) annual meeting (July 20–24, 2014, Austin, TX, USA), where some specific sessions will be covering the latest advances in MRI-guided radiotherapy.

Related Links:

Elekta 
Philips Healthcare 
Institute of Cancer Research, London



Channels

Radiography

view channel
Image: The AeroDR Premium is an extremely light cassette-type digital radiography detector with improved strength (Photo courtesy of Konica Minolta).

Cassette-Type Digital Radiography Detector Designed to Reduce Waiting Times

Key features of a new cassette-type digital radiography (DR) system includes an extremely light weight of 2.6 kg; improved load resistance and drop impact resistance; and reduced waiting time due to shortened... Read more

Ultrasound

view channel
Image: Purdue University researchers are using ultrasound images like this one to study abdominal aortic aneurysms, a potentially fatal condition that is the 13th leading cause of death in the United States (Photo courtesy of Purdue University/Weldon School of Biomedical Engineering).

Ultrasound Provides Insights into Abdominal Aortic Aneurysms

Researchers are assessing the effectiveness of the use of ultrasound to study lethal abdominal aortic aneurysms (AAAs), a bulging of the aorta that is typically fatal when it ruptures, and for which there... Read more

Nuclear medicine

view channel
Image: Symbia Evo Excel combines excellent SPECT image resolution and detector sensitivity with a small room size requirement thus designed to fit into almost any existing nuclear medicine exam room (Photo courtesy of Siemens Healthcare).

New SPECT System Scans Virtually Every Patient and Is Designed to Fit into Most Nuclear Medicine Exam Rooms

A new single photon emission computed tomography (SPECT) system combines image resolution and detector sensitivity with the smallest room size requirement in its class. Siemens Healthcare’s (Erlangen,... Read more

General/Advanced Imaging

view channel
Image: A collaborative effort between EPFL, CNRS, ENS Lyon, CPE Lyon, and ETH Zürich has led to the development of a novel approach that can considerably improve the capabilities of medical imaging with safer procedures for the patient (Photo courtesy of EPFL - Ecole Polytechnique Fédérale de Lausanne).

Collaboration to Make Diagnostic Medical Imaging Less Hazardous Using Hyperpolarization Agents

A collaborative effort by scientists has led to the development of an innovative strategy that can considerably improve the capabilities of medical imaging with safer procedures for the patient.... Read more

Imaging IT

view channel
Image: The Coronis Uniti diagnostic image display supports PACS and breast imaging in color and grayscale (Photo courtesy of Barco).

Diagnostic Image Display Designed for Both PACS and Breast Imaging

The first diagnostic display designed for both picture archiving and communication systems (PACS) and breast imaging provides excellent image quality, inventive productivity features, and a focus on ergonomics.... Read more

Industry News

view channel

Global Partnership Provides Treatment Planning Support for Modulated Arc Radiotherapy

Varian Medical Systems (Palo Alto, CA, USA) Eclipse treatment planning software can now be used to plan modulated arc radiotherapy (mARC) treatments at sites using Siemens Healthcare (Erlangen, Germany) medical linear accelerators. Varian Medical Systems and Siemens Healthcare presented their range of solutions that... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.